Clinical Trials Logo

Cytokines clinical trials

View clinical trials related to Cytokines.

Filter by:

NCT ID: NCT04226573 Completed - Clinical trials for Preoperative Anxiety

Effect of Preoperative Anxiety on Fetus in Pregnant Women

Start date: February 1, 2020
Phase:
Study type: Observational

In the preoperative period, 60-80% of the patients had anxiety symptoms. This rate increases even more during pregnancy. There are a number of studies examining the role of anxiety symptoms on fetal outcome, but the mechanisms that explain the effects of maternal stress are not fully understood. The most extensively studied cytokines in neuropsychiatric disorders are TNF-α and IL-6 due to their effects on the central nervous system. TNF-α levels have been reported to be elevated in anxiety disorders. In our study, the investigators aimed to determine the relationship between preoperative anxiety levels and fetal cord blood TNF-α and IL-6 cytokine levels in pregnant women.

NCT ID: NCT03623763 Suspended - Athletes Clinical Trials

Vitamin D Level Among Athletes in Uzbekistan

Start date: January 1, 2017
Phase:
Study type: Observational [Patient Registry]

The purpose of the study is to determine vitamin D (VD) levels and upper respiratory tract infections (URTI) morbidity among elite athletes engaged in water sports in Uzbekistan. Serum levels of 25(OH) VD and TNF-α, IFN-γ, IL-4 and IL-6 will be detected by ELISA technique among elite athletes and control population in spring and autumn.

NCT ID: NCT03264846 Completed - Clinical trials for Polycystic Ovary Syndrome

Endocan Levels at Polycystic Ovary Syndrome and Periodontal Inflammation

Start date: April 3, 2017
Phase:
Study type: Observational [Patient Registry]

Periodontal diseases are chronic inflammatory disease occurred by the interaction between pathogenic microorganism and the host defense. Polycystic ovary syndrome (PCOS) is a reproductive and metabolic disease associated with increased risk of cardiovascular events. Endocan is a proteoglycan secreted mainly by endothelial cells under the control of inflammatory cytokines. Periodontal diseases, including gingivitis, are common chronic infectious diseases caused by predominantly pathogenic microorganisms that colonize the subgingival area and cause local and systemic elevations of proinflammatory cytokines such as Interleukin-6 (IL-6). Several lines of evidence established the association between periodontal and systemic diseases, including metabolic syndrome, diabetes, and cardiovascular disease. Because of the fact that both periodontal disease and PCOS are associated with systemic inflammation and insulin resistance, these two disorders may be linked through a common pathophysiologic pathway. A number of studies have indicated a possible relationship between PCOS and periodontal inflammation. Despite common risk factors, including oxidative stress, the relationship between chronic periodontitis (CP) and PCOS remains unclear. The aims of the study were to determine serum and saliva Endocan and IL-6 levels and to evaluate the correlation between these two biomarker in women with periodontal disease and PCOS.

NCT ID: NCT02871947 Recruiting - Bronchial Asthma Clinical Trials

Epidemiology and Cytokines Analysis of Severe Asthma Patients in Taiwan

Start date: March 2016
Phase: N/A
Study type: Observational

Severe asthma is a heterogeneous disease characterized by the need for treatment with high doses of inhaled corticosteroids. It affects 5%-10% of asthmatic patients, although it accounts for a significant percentage of the consumption of health care resources. Severe asthma comprises various clinical and pathophysiological phenotypes. In this current study, we aimed to clinical characteristics and cytokes profile in severe asthma patients.

NCT ID: NCT02112864 Recruiting - Chronic Pain Clinical Trials

Dexamethasone for Reduction of Post Thoracotomy Pain Syndrome

Start date: May 2014
Phase: N/A
Study type: Interventional

Post thoracotomy pain syndrome still affects 50% of patients after a thoracic surgery. Pathogenesis is unclear but there is growing evidence that neuro inflammation may play a significant role. Dexamethasone is a very potent anti-inflammatory drug. The hypothesis of this study is that dexamethasone, given pre operatively, would help reduce the incidence of post thoracotomy pain syndrome 3 months after surgery, by reducing the inflammatory response, in patients undergoing elective thoracic surgery that includes thoracic epidural analgesia.

NCT ID: NCT01895699 Completed - Clinical trials for Endothelial Function

The Effect of Contrast Agent on Endothelial Function in Healthy Men

Start date: July 2013
Phase: Phase 4
Study type: Interventional

Contrast medium is essential for diagnosis of many diseases. However, recent studies showed that contrast agents can induce renal injury and is associated with poor long-term clinical outcome, especially in diabetes. To date, no data are available on the relationship between contrast medium and endothelial function. Endothelial dysfunction is known to precede atherosclerosis and is considered a risk marker for future development of cardiovascular disease. Therefore, we hypothesized that contrast agents may induce endothelial dysfunction in healthy men. In addition, we hypothesized that contrast induced endothelial dysfunction via free radicals. Thus, we also test alpha-lipoic acid whether or not protect endothelial dysfunction induced by contrast agents.

NCT ID: NCT01657656 Completed - Tuberculosis Clinical Trials

Vitamin D Supplementations as Adjunct to Anti-Tuberculosis Drugs in Mongolia

Start date: October 2012
Phase: N/A
Study type: Interventional

Hypothesis That improving vitamin D status among TB patients will speed the pace of bacteriological cure, and will enhance immune responses to TB infection

NCT ID: NCT01231477 Completed - Sevoflurane Clinical Trials

Cytokines and Sevoflurane During Surgery

Start date: July 2009
Phase: N/A
Study type: Observational

The aim of the present study was to evaluate the effects of anaesthesia with sevoflurane and surgery on cytokines response.

NCT ID: NCT01115842 Unknown status - Clinical trials for Acute Coronary Syndrome

Vitamin D and Inflammatory Cytokine Levels After Acute Myocardial Infraction (MI)

Start date: June 2010
Phase: Phase 4
Study type: Interventional

Vitamin D is known to have immune-modulator effects including suppression of proinflammatory cytokine expression and regulation of immune cell activity. Vitamin D supplementation has been associated with a reduction in pro-inflammatory cytokines in patients with heart failure, and vitamin D deficiency has been associated with higher rates of myocardial infarcts. The levels of pro and anti-inflammatory cytokines also effect the outcome after acute coronary events. The proposed interventional study is targeted as a feasibility study targeted at assessing the role of vitamin D as an anti-inflammatory mediator. The study is planned as a randomized open label interventional trial. The study will be conducted of 50 adult patients (25 interventional group, 25 control), all from the internal ward in "Meir" medical center. Patients which are admitted after an acute coronary event will be randomized to the Vitamin D supplementation group or to the control group. the vitamin D group will receive 4000IU per day of vitamin D for five days. Cytokine levels will be measured at day 1 and at day 5. follow up will be continued for 6 months Primary end point: Levels of immune mediating cytokines (CRP, TNF-α. Il-2, IL-6, IL-12 and IL-10) after a five day intervention in patients serum. Secondary endpoints: Any major cardiovascular event within follow-up period. Any death of any cause during follow-up period Expected results: the investigators expect vitamin D supplementation after a pro-inflammatory state such as an acute coronary event, combined with conventional therapy, to result in decreased levels of inflammatory serum bio-markers.

NCT ID: NCT01101204 Not yet recruiting - Diabetes Clinical Trials

The Effects of Hypolipemic and Antidiabetic Treatment on Cytokines

MSF
Start date: July 2012
Phase: N/A
Study type: Interventional

The study is planned to show whether combined hypolipemic and antidiabetic therapy with various daily dosages influence the fasting plasma glucose, insulin sensitivity and proinflammatory cytokines in diabetic and dyslipidemic subjects.